Company / SG&A per Share
Protagonist Therapeutics, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.71
FY2025
5-year range
$0.59 / $0.71
FY2021-FY2025
Trend
+5.6%
vs FY2024
Sector context
#145 of 210
Health Care
What the data says
At $0.71, Protagonist Therapeutics, Inc.'s sg&a per share ranks #66 of 210 in the Health Care sector. SG&A per Share has fluctuated over the past 10 years, ranging from $0.54 in FY2020 to $1.07 in FY2016.
Based on SEC 10-K filings.
0.71 in FY2025 with a 5-year CAGR of +5.4%.
Increased from $0.59 to $0.71 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +2.9%
- 5-Year CAGR
- +5.4%
- 10-Year CAGR
- -
Sector benchmark
#66 of 210 in Health CareTop 31% of 210This company $0.71 Sector average $40.75
▼
-98.3% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 5.6% year-over-year.
- Ranks #145 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2016.
- Lowest sg&a per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 4.66 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.71 | +5.6% |
| FY2024 | $0.67 | +13.2% |
| FY2023 | $0.59 | -8.8% |
| FY2022 | $0.65 | +10.2% |
| FY2021 | $0.59 | +8.3% |
| FY2020 | $0.54 | -10.9% |
| FY2019 | $0.61 | -0.7% |
| FY2018 | $0.61 | -8.0% |
| FY2017 | $0.67 | -37.8% |
| FY2016 | $1.07 | -90.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026